Irene Miedema, Gert-Jan Luijckx, Maarten Uyttenboogaart. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Anticoagulants/adverse effectsBrain Ischemia/epidemiologyFemaleFibrinolytic Agents/administration & dosageHumansMaleStroke/drug therapyTissue Plasminogen Activator/administration & dosageWarfarin/adverse effects
Substances： See more » AnticoagulantsFibrinolytic AgentsWarfarinTissue Plasminogen Activator
Year: 2012 PMID： 23032535 DOI： 10.1001/2012.jama.11664
Source DB: PubMed Journal: JAMA ISSN： 0098-7484 Impact factor: 56.272